Professor, Internal Medicine, University of Cincinnati College of Medicine
Internal Medicine
Dr. Mark H. Eckman, MD
|
|
Give Review
Mark H. Eckman, MD works in the field of Internal Medicine. He researched medicine at Albany Medical College. He received 12 awards: "Cincinnati Health Care Leadership Award", "Eugene L. Sanger Award for Distinguished Service", "Merit Award", "Whos Who in America, 58th edition", "Top Doctors", "Best Doctors in America", "Faculty Recognition Award for Excellence in Teaching", "Student Prize Award", "Lusted Student Prize Award", "Appointment to fellowship", "Fund Research Award" and "Lee B. Lusted PostDoctoral Paper Competition (2nd place)". Mark Eckman has written publications. He has 85 publications published with PubMed. The lastest publication is: 'Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues.'
Publications
- Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.
- Cost-effectiveness of total pancreatectomy and islet cell autotransplantation for the treatment of minimal change chronic pancreatitis.
- Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: Early is not always better.
- Cost-effectiveness of intravenous acetaminophen for pediatric tonsillectomy.
- The Use of z Scores in Probabilistic Sensitivity Analyses.
- Predictors of bariatric surgery among an interested population.
- Cost-effectiveness of screening for chronic hepatitis C infection in the United States.
- Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children.
- Impact of health literacy on outcomes and effectiveness of an educational intervention in patients with chronic diseases.
- The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States.
- Statin use following intracerebral hemorrhage: a decision analysis.
- Reply: Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long-term clinical trials.
- Erratum to: Thiopurine S-Methyltransferase Testing in Idiopathic Pulmonary Fibrosis: A Pharmacogenetic Cost-Effectiveness Analysis.
- The potential of shared decision making to reduce health disparities.
- Cost-effectiveness of telemetry for hospitalized patients with low-risk chest pain.
- Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation.
- Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: a decision analysis.
- Thiopurine S-methyltranferase testing in idiopathic pulmonary fibrosis: a pharmacogenetic cost-effectiveness analysis.
- Longitudinal analysis of genitourinary and bowel symptoms in prostate cancer patients following brachytherapy.
- Outcomes of hemodialysis patients in a long-term care hospital setting: a single-center study.
- Decision modeling to estimate the impact of gastric bypass surgery on life expectancy for the treatment of morbid obesity.
- Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials.
- Should we test for CYP2C9 before initiating anticoagulant therapy in patients with atrial fibrillation?
- Cost-effectiveness analysis of ED decision making in patients with non-high-risk heart failure.
- Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
- Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.
- A randomized study of scleroderma health state values: a picture is worth a thousand words, and quite a few utiles. [corrected].
- Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?
- Patient-specific decision modeling to guide the use of drotrecogin alpha (activated) in patients with severe sepsis.
- Oral cyclophosphamide for active scleroderma lung disease: a decision analysis.
- Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation.
- Racial disparities in the filling of warfarin prescriptions for nonvalvular atrial fibrillation.
- Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin.
- "Bridging on the river Kwai": the perioperative management of anticoagulation therapy.
- Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.
- Underuse of controller medications among children with persistent asthma in the Ohio medicaid population: evolving differences with new medications.
- Radioiodine or surgery for toxic thyroid adenoma: dissecting an important decision. A cost-effectiveness analysis.
- Presidential reflections on the 25th anniversary of the society for medical decision making.
- The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage.
- Use of regression modeling to simulate patient-specific decision analysis for patients with nonvalvular atrial fibrillation.
- Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation.
- Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis.
- Screening for the risk for bleeding or thrombosis.
- Health values of adolescents with cystic fibrosis.
- The impact of expected HIV transmission rates on the effectiveness and cost of ruling out HIV infection in infants.
- Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis.
- Antithrombotic therapy in valvular heart disease.
- Decision analytic and cost-effectiveness issues concerning anticoagulant prophylaxis in heart disease.
- Direct angioplasty for acute myocardial infarction. A review of outcomes in clinical subsets.
- Prophylactic use of the intra-aortic balloon pump in high-risk cardiac patients undergoing noncardiac surgery: a decision analytic view.
- Anticoagulation for noncardiac procedures in patients with prosthetic heart valves. Does low risk mean high cost?
- A counterpoint to the analytic hierarchy process.
- Biologic complexity in mathematical modeling.
- EHR-based Clinical Trial Alert Effects on Recruitment to a Neurology Trial across Institutions: Interim Analysis of a Randomized Controlled Study.
- A decision analytic view of anticoagulant prophylaxis for thromboembolism in heart disease.
- Warfarin for dilated cardiomyopathy: a bloody tough pill to swallow?
- Automated critiquing of medical decision trees.
- Aortic aneurysm in a 74-year-old man with coronary disease and obstructive lung disease: is double jeopardy enough?
- Bone marrow donor registries: the relation between registry size and probability of finding complete and partial matches.
- Eaton-Lambert syndrome and small cell lung cancer: side effects and certainty.
- The timing of radical cystectomy after recent myocardial infarction: waiting for Godot.
- Screening for prostate cancer. A decision analytic view.
- Making decisions about antithrombotic therapy in heart disease. Decision analytic and cost-effectiveness issues.
- Clinical impact of inaccuracies in anticoagulation monitoring.
- Foot infections in diabetic patients. Decision and cost-effectiveness analyses.
- Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy.
- Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states: a risky business.
- Inaccuracies in estimates of life expectancies of patients with bronchial cancer in clinical decision making.
- Patient-specific decisions about hormone replacement therapy in postmenopausal women.
- Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis.
- Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation.
- Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues.
- Finding what you seek: analyzing therapies for nonvalvular atrial fibrillation.
- HLA-matched donor registries for bone marrow transplants. A decision analysis.
- Therapeutic controversy: Hormone replacement therapy--where are we going?
- Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women.
- Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia.
- Patient-centered decision making: a view of the past and a look toward the future.
- Valuation of scleroderma and psoriatic arthritis health states by the general public.
- Understanding preferences for disclosure of individual biomarker results among participants in a longitudinal birth cohort.
- Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
- Grades of recommendation for antithrombotic agents.
- Determinants of hospitalist efficiency: a qualitative and quantitative study.
- Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease.
Schools
Albany Medical College
Albany Memorial Hospital
Tufts New England Med Center
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Cincinnati Health Care Leadership Award
- Eugene L. Sanger Award for Distinguished Service
- Merit Award
- Who’s Who in America, 58th edition
- Top Doctors
- Best Doctors in America
- Faculty Recognition Award for Excellence in Teaching
- Student Prize Award
- Lusted Student Prize Award
- Appointment to fellowship
- Fund Research Award
- Lee B. Lusted PostDoctoral Paper Competition (2nd place)
Education
-
Albany Medical Center -
Albany Medical College -
Northwestern University
Hospital
-
University of Cincinnati Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164487039 |
| Last Name Of The Provider | ECKMAN |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Benjamin Costello, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Georges M. Feghali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Muhammad B. Khan, MD |
|
|
Dr. Jacob B. Osterbur, DO |
|
|
Dr. Mylea N. Wiley, MD |
|
|
Dr. Ashina D. Singh, MD |
|
|
Dr. Sudhagar Thangarasu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Puja Srivastava, MD |